1. Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors
- Author
-
Liliana Gadola, María Jimena Cabrera, Mariela Garau, Ruben Coitiño, María Haydée Aunchayna, Oscar Noboa, María Asunción Alvarez, Sylvia Balardini, Graciela Desiderio, Nelson Dibello, Alejandro Ferreiro, Soledad Giró, Leonella Luzardo, Alfredo Maino, Lucía Orihuela, María Gabriela Ottati, and Andrés Urrestarazú
- Subjects
IgA nephropathy ,risk factors ,kidney replacement therapy ,outcomes ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
AbstractAim IgA nephropathy (IgAN), the most common glomerulopathy worldwide and in Uruguay, raised treatment controversies. The study aimed to analyze long-term IgAN outcomes and treatment.Methods A retrospective analysis of a Uruguayan IgAN cohort, enrolled between 1985 and 2009 and followed up until 2020, was performed. The Ethics Committee approved the study. The inclusion criteria were (a) biopsy-proven IgAN; (b) age ≥12 years; and (c) available clinical, histologic, and treatment data. The patients were divided into two groups, with immunosuppressive (IS) or without (NoIS) treatment. Outcomes (end-stage kidney disease/kidney replacement therapy [ESKD/KRT] or all-cause death) were obtained from mandatory national registries.Results The study population included 241 patients (64.7% men), median age 32 (19.5) years, baseline blood pressure
- Published
- 2023
- Full Text
- View/download PDF